Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)

Market Cap	3.11B -32.9%
Revenue (ttm)	615.76M +3.1%
Net Income	45.14M -56.1%
EPS	0.37 -56.0%
Shares Out	120.45M
PE Ratio	69.43
Forward PE	n/a
Dividend	0.90 (3.49%)
Ex-Dividend Date	Jun 2, 2026

Volume	2,507,664
Open	26.36
Previous Close	26.32
Day's Range	25.65 - 26.91
52-Week Range	23.80 - 48.60
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About SHE:301509

Kingchem (Liaoning) Life Science Co., Ltd. engages in the provision of small molecule CDMO services in China and internationally. The company offers fluorine-containing products, such as benzene intermediates of trifluoromethoxy or trifluoromethyl groups, and fluoroaromatic intermediates. It also provides non-fluorinated products, including nitrogen-containing heterocyclic compounds, aliphatic organic derivatives of ammonia, carboxylic acids and their derivatives, alkenes, non-fluorinated halobenzenes, phenols, ketones, and isocyanates. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2009
• Employees: 690
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301509

Financial Performance

In 2025, SHE:301509's revenue was 639.37 million, an increase of 28.64% compared to the previous year's 497.01 million. Earnings were 104.81 million, an increase of 171.46%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 13, 2026

Data Sources Report a data error